Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04544501 · ClinicalTrials.gov registry record · NA
Enhance the Use of Genetic Counseling and Testing in Latinas
A NA study of Hereditary Breast and Ovarian Cancer Syndrome, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
- 4
- Study locations
NCT04544501: Completed NA study of Hereditary Breast and Ovarian Cancer Syndrome, sponsored by Georgetown University.
NCT04544501 is a NA study of Hereditary Breast and Ovarian Cancer Syndrome that has completed, run by Georgetown University. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04544501, a NA study of Hereditary Breast and Ovarian Cancer Syndrome, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
- 4
- Study locations
Study Summary
The investigators will conduct a two-arm RCT to evaluate the preliminary effectiveness of a culturally-adapted video developed by the team vs. a FORCE fact sheet on enhancing genetic cancer risk assessment (GCRA; including genetic counseling and option for genetic testing) uptake and psychosocial outcomes among Latinas at increased risk for hereditary breast and ovarian cancer (HBOC).
Primary Outcome
Proportion of participants that receive genetic counseling. The outcome will be assessed by self-report (e.g., Have you received genetic counseling in the past three months?) and confirmed with the genetic counseling company records.
Conditions Studied
Interventions
- BEHAVIORAL Culturally-Targeted Video
- OTHER FORCE Fact Sheet
Study Locations (4)
Virginia
- Nueva Vida - Alexandria
- Arlington Free Clinic - Arlington
- Virginia Commonwealth University - Richmond
District of Columbia
- Capital Breast Care Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2020-02-24 |
| Est. Completion | 2022-01-31 |
| Phase | NA |
What the finished NCT04544501 record still lists
NCT04544501 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Hereditary Breast and Ovarian Cancer Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Culturally-Targeted Video is the first listed.
NCT04544501 reports a single indexed study location in Virginia, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04544501 about?
NCT04544501 is a clinical study titled "Enhance the Use of Genetic Counseling and Testing in Latinas". The investigators will conduct a two-arm RCT to evaluate the preliminary effectiveness of a culturally-adapted video developed by the team vs. a FORCE fact sheet on enhancing genetic cancer risk assessment (GCRA; including genetic counseling and option for genetic testing) uptake and psychosocial ou...
What is the current status of trial NCT04544501?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2020-02-24. Estimated completion is 2022-01-31.
What conditions does trial NCT04544501 study?
This clinical trial studies the following conditions: Hereditary Breast and Ovarian Cancer Syndrome.
What interventions are being tested in trial NCT04544501?
The interventions under investigation include: Culturally-Targeted Video (BEHAVIORAL), FORCE Fact Sheet (OTHER).
Who is sponsoring clinical trial NCT04544501?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04544501 being conducted?
This trial has 4 study locations across District of Columbia, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hereditary Breast and Ovarian Cancer Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04544501's enrollment target sits among peer trials
61 1164th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI